79 Days
Source:
بوابة الوسط
بوابة الوسط
Ready to play
Ready to play
A comprehensive study has shown that obesity medications in the GLP-1 class are more effective but can cause significant side effects. The weight loss with some of these medications reaches about 15%. However, research has not demonstrated a tangible improvement in patients' quality of life. The study also addressed complications such as digestive issues and confirmed that certain drugs, like Tirzepatide and Semaglutide, show promising results in weight loss and reducing the risk of heart diseases. Nonetheless, their long-term effects remain unclear, prompting the need for further research.
Notice: This Is an AI-Generated Summary
Comments (0)